BioCorRx Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 0.008817 million compared to USD 0.029809 million a year ago. Net loss was USD 1.36 million compared to USD 0.767661 million a year ago. Basic loss per share from continuing operations was USD 0.21 compared to USD 0.14 a year ago. For the nine months, sales was USD 0.034659 million compared to USD 0.100399 million a year ago. Net loss was USD 4.01 million compared to USD 2.57 million a year ago. Basic loss per share from continuing operations was USD 0.62 compared to USD 0.48 a year ago.